What is Mass General Brigham investing in? 21 companies in the health system's portfolio

Boston-based Mass General Brigham has a large venture capital arm, Mass General Brigham Ventures, and has made some notable investments in the life sciences, biotech, medtech and digital health spaces.

Here are 21 companies in Mass General's portfolio:

1. Abscuro
2. Affinia Therapeutics
3. Amolyt Pharma
4. Claris Bio
5. FireCyte Therapeutics
6. Garuda Therapeutics
7. InStride Health
8. Lyndra Therapeutics
9. Mediar Therapeutics
10. Nocion Therapeutics
11. Paros Bio
12. Photys
13. Pykus
14. QurAlis
15. Rippl Care
16. ROME Therapeutics
17. Scorpion Therapeutics
18. SeQure Dx
19. SwanBio Therapeutics
20. Walden Biosciences
21. Ziel Bio